GlassScriptPhysician profile
Christopher W Barber
NPI 1316172562
$3,290.26
in general payments reported to CMS, 2019-2025
23 companies · $34.71 in 2025
The $34.71 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,827 · 2020: $225 · 2021: $472 · 2022: $606 · 2023: $17.45 · 2024: $109 · 2025: $34.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $160.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $679.28 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $642.17 | 2019-2022 | |
| United Therapeutics Corporation | $315.93 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $310.07 | 2019-2021 | |
| Glaxosmithkline, LLC. | $186.72 | 2019-2020 | |
| Genentech USA, INC. | $149.91 | 2019-2020 | |
| Abbott Laboratories | $149.12 | 2021 | |
| Pfizer INC. | $133.66 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $131.72 | 2019 | |
| Sandoz INC. | $119.81 | 2022 | |
| Merck Sharp & Dohme LLC | $92.06 | 2024 | Winrevair |
| Philips North America LLC | $85.67 | 2020-2022 | |
| La Jolla Pharmaceutical Company | $72.13 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $52.34 | 2019-2020 | |
| Mylan Specialty L.P. | $48.71 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $18.23 | 2019 | |
| Jazz Pharmaceuticals INC. | $16.91 | 2019 | |
| Inari Medical, INC. | $16.84 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Grifols USA, LLC | $16.38 | 2020 | |
| Eisai INC. | $14.26 | 2021 | |
| Viiv Healthcare Company | $13.34 | 2019 | |
| Advanced Respiratory, INC | $13.00 | 2019 | |
| Csl Behring | $12.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Barber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.